gw0742
Development of PPAR-agonist GW0742 as antidiabetic drug
GW0742 is a potent PPARβ and PPARδ agonist, with an IC50 of 1 nM for human PPARδ in binding assay, and EC50s of 1 nM, μM and 2 μM for human PPARδ,
Regular
ราคา
1000 ฿ THB
Regular
ราคา
Sale
ราคา
1000 ฿ THB
ราคาต่อหน่วย
/
per
เว็บไซต์ gw0742 GW0742 is a potent PPARβ and PPARδ agonist, with an IC50 of 1 nM for human PPARδ in binding assay, and EC50s of 1 nM, μM and 2 μM for human PPARδ, gw0742 GW-0742X GW0742 Database Links Click here for help BindingDB Ligand, 50127222 CAS Registry No 317318-84-6 ChEMBL Ligand, CHEMBL38508
gw0742 Avis client GW0742 is a potent PPARβ and PPARδ agonist, with an IC50 of 1 nM for human PPARδ, and EC50s of 1 nM, μM and 2 μM for human PPARδ, PPARα, and Endurine GW0742 is a selective Peroxisome Proliferator Receptor Agonist Improve GW0742 controls Type 1 Diabetes in rats Studies have shown that GW0742 has off target, non- PPARβδ effects in the cell although there are